Assessment of the Monitor Unit Objective tool for VMAT in the Eclipse treatment planning system

For the three studied clinical sites, establishing MaxMU = 400 led to the optimum MU reduction, maintaining the original dose distribution and dosimetric parameters practically unaltered.